Reverse Fox test for detecting visuospatial dysfunction corresponding to parietal hypoperfusion in mild Alzheimer's...

Area of Science:

• Neuroscience
• Clinical Neurology
• Medical Imaging

Background:

• Mild Alzheimer's disease (AD) poses diagnostic challenges, particularly in detecting early parietal lobe dysfunction.
• Existing clinical tasks may not sufficiently capture subtle visuospatial deficits characteristic of early AD.

Purpose of the Study:

• To introduce and validate a novel visuospatial clinical task, the "Reverse Fox" test.
• To assess the efficacy of the Reverse Fox test in detecting parietal dysfunction in mild Alzheimer's disease.
• To correlate test performance with neuroimaging findings in mild AD patients.

Main Methods:

• A cohort of 65 outpatients (47 with mild AD, 18 healthy controls) performed the Reverse Fox test.
• Brain single photon emission tomography (SPECT) was utilized to assess regional cerebral blood flow.
• Alzheimer's disease patients were stratified into successful and unsuccessful Reverse Fox test subgroups.

Main Results:

• Only 31.9% of mild AD patients successfully completed the Reverse Fox test, compared to 94.4% of healthy controls.
• The unsuccessful AD subgroup exhibited significantly reduced medial parietal and bilateral temporoparietal perfusion on SPECT.
• These perfusion deficits were directly linked to failures in the Reverse Fox test.

Conclusions:

• Failure in the Reverse Fox test is associated with parietal hypoperfusion in individuals with mild Alzheimer's disease.
• The Reverse Fox test demonstrates potential as a valuable supporting tool for early Alzheimer's disease detection in outpatient settings.
• This visuospatial task offers a promising avenue for identifying parietal dysfunction indicative of mild AD.